Back
Greenpro Capital Vs. Avidity Biosciences Industry Stock Comparison
Sell
37
GRNQ
Greenpro Capital
Last Price:
$0.91
Seasonality Move:
11.9%
Sell
25
RNA
Avidity Biosciences
Last Price:
$30.84
Seasonality Move:
0%
Sell
37
Greenpro Capital (GRNQ)
is a Sell
Is Greenpro Capital a Buy, Sell or Hold?
-
The current Greenpro Capital [GRNQ] share price is $0.93. The Score for GRNQ is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
GRNQ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $30.84. The Score for RNA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRNQ Stock Price Chart
What is Greenpro Capital's stock price today?
-
The Greenpro Capital share price today is $0.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRNQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $30.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight buying pressure.
GRNQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 45.44 | Sell |
Chaikin Money Flow: | 339 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.91 - 1.01) | Sell |
Bollinger Bands (100): | (0.89 - 1.15) | Sell |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 48.83 | Sell |
Chaikin Money Flow: | 549842 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.62 - 32.34) | Sell |
Bollinger Bands (100): | (29.04 - 41.76) | Sell |
GRNQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.91 | Buy |
20-day SMA: | 0.94 | Sell |
50-day SMA: | 1.03 | Sell |
200-day SMA: | 1 | Sell |
8-day EMA: | 0.92 | Buy |
20-day EMA: | 0.95 | Sell |
50-day EMA: | 0.99 | Sell |
200-day EMA: | 1.05 | Sell |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.69 | Sell |
20-day SMA: | 30.67 | Buy |
50-day SMA: | 31.11 | Sell |
200-day SMA: | 38.69 | Sell |
8-day EMA: | 31.19 | Sell |
20-day EMA: | 31.15 | Sell |
50-day EMA: | 32.04 | Sell |
200-day EMA: | 33.88 | Sell |
Greenpro Capital Earnings Growth & GRNQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.96 per share, and a decrease next year of $0.48 per share.
Greenpro Capital Technical Analysis
Mar 10 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |